Is Seagen (SGEN) making Money?
However, Seagen (NASDAQ: SGEN) is not making money from its cancer drugs. For instance, Seagen reported a quarterly operating loss of -$93.97 million on 30 June 2020.
Read MoreIn individuals, insanity is rare; but in groups, parties, nations and epochs, it is the rule. Friedrich Nietzsche
However, Seagen (NASDAQ: SGEN) is not making money from its cancer drugs. For instance, Seagen reported a quarterly operating loss of -$93.97 million on 30 June 2020.
Read More